GIC Sub-Industry »Biotechnology« (200+)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
200 matches
| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
Biotechnology
Immunology Drugs, Oncology Medicines, Aesthetics |
401B | 44 | -0.19 | 60 | 47 | 3.2% |
| NOV XETRA Novo Nordisk |
Biotechnology
Insulin, Weight Loss Drugs, Growth Hormones |
193B | 65 | 0.22 | 81 | 86 | 4.6% |
| AMGN NASDAQ Amgen |
Biotechnology
Biopharmaceuticals, Oncology Drugs, Inflammation |
187B | 57 | -1.13 | 63 | 46 | 3.0% |
| GILD NASDAQ Gilead Sciences |
Biotechnology
Antivirals, Oncology, Cell Therapy, Immunotherapy |
160B | 61 | -1.51 | 84 | 23 | 2.7% |
| VRTX NASDAQ Vertex Pharmaceuticals |
Biotechnology
Cystic Fibrosis Drugs, Gene Therapies, Pain |
113B | 49 | -0.87 | 74 | 22 | - |
| REGN NASDAQ Regeneron Pharmaceuticals |
Biotechnology
Ophthalmology Drugs, Immunology Drugs, Oncology |
66.8B | 54 | -0.95 | 81 | 18 | 0.5% |
| ARGX NASDAQ argenx |
Biotechnology
Autoimmune Therapies, Monoclonal Antibodies |
55.6B | 72 | -0.14 | 80 | 72 | - |
| ALNY NASDAQ Alnylam Pharmaceuticals |
Biotechnology
RNAi Therapeutics, Rare Disease Drugs, Genetic |
40.5B | 46 | -0.98 | 59 | 10 | - |
| HLN NYSE Haleon |
Biotechnology
Oral Care, Vitamins, Pain Relief, Respiratory |
40.3B | 47 | -0.88 | 73 | 17 | 1.9% |
| RVMD NASDAQ Revolution Medicines |
Biotechnology
Oncology Drugs, RAS Inhibitors, Cancer Therapies |
31.7B | 34 | -0.44 | 47 | 99 | - |
| NTRA NASDAQ Natera |
Biotechnology
Prenatal Testing, Oncology Diagnostics, Organ |
30.8B | 51 | -0.64 | 34 | 64 | - |
| BIIB NASDAQ Biogen |
Biotechnology
Neurology Drugs, Multiple Sclerosis, Biosimilars |
28.8B | 63 | -0.53 | 76 | 73 | - |
| ONC NASDAQ BeiGene |
Biotechnology
Small Molecule Inhibitors, Immunotherapy |
28.0B | 52 | -0.63 | 78 | 14 | - |
| UTHR NASDAQ United Therapeutics |
Biotechnology
Vasodilators, Monoclonal Antibodies, Infusion |
23.1B | 67 | -0.33 | 91 | 82 | - |
| BNTX NASDAQ BioNTech SE |
Biotechnology
mRNA Vaccines, Oncology Drugs, Infectious Disease |
22.3B | 30 | -1.02 | 80 | 18 | - |
| INCY NASDAQ Incyte |
Biotechnology
Oncology Drugs, Kinase Inhibitors, Dermatology |
20.5B | 72 | -0.19 | 84 | 75 | - |
| INSM NASDAQ Insmed |
Biotechnology
Antibiotics, Enzyme Inhibitors, Gene Therapies |
20.4B | 23 | -1.09 | 18 | 4 | - |
| ROIV NASDAQ Roivant Sciences |
Biotechnology
Monoclonal Antibodies, Small Molecules, Delivery |
20.4B | 37 | -0.10 | 38 | 93 | - |
| MRNA NASDAQ Moderna |
Biotechnology
mRNA Vaccines, Cancer Immunotherapy, Rare Disease |
18.8B | 45 | -0.29 | 78 | 86 | - |
| NBIX NASDAQ Neurocrine Biosciences |
Biotechnology
Movement Disorder Drugs, Endocrine Treatments |
16.5B | 71 | 0.20 | 84 | 72 | - |
| GMAB NASDAQ Genmab AS |
Biotechnology
Antibodies, Cancer Therapies, Immunotherapy |
15.4B | 32 | -1.13 | 17 | 16 | - |
| EXEL NASDAQ Exelixis |
Biotechnology
Oncology Medicines, Kinase Inhibitors, Cancer |
13.2B | 70 | 0.83 | 83 | 82 | - |
| BBIO NASDAQ BridgeBio Pharma |
Biotechnology
Genetic Medicines, TTR Stabilizers, Kinase |
13.2B | 30 | -0.40 | 29 | 64 | - |
| ERF PA Eurofins Scientific SE |
Biotechnology
Laboratory Testing, Clinical Diagnostics, Genomic |
13.1B | 43 | -0.49 | 36 | 50 | 1.2% |
| ASND NASDAQ Ascendis Pharma AS |
Biotechnology
Growth Hormones, Endocrinology Therapies |
12.9B | 36 | -0.76 | 27 | 32 | - |
| IONS NASDAQ Ionis Pharmaceuticals |
Biotechnology
RNA Medicines, Biotechnology, Genetic Therapies |
12.2B | 50 | -0.52 | 64 | 74 | - |
| MDGL NASDAQ Madrigal Pharmaceuticals |
Biotechnology
Liver Therapeutics, Metabolic Drugs, Hormone |
11.3B | 35 | -0.98 | 28 | 68 | - |
| SMMT NASDAQ Summit Therapeutics |
Biotechnology
Bispecific Antibodies, Immunotherapy, Oncology |
11.2B | 11 | -0.87 | 42 | 5 | - |
| BMRN NASDAQ Biomarin Pharmaceutical |
Biotechnology
Enzyme Therapies, Growth Treatments, Gene |
11.0B | 38 | -0.36 | 81 | 24 | - |
| ARWR NASDAQ Arrowhead Pharmaceuticals |
Biotechnology
RNAi Therapeutics, Genetic Medicines, Liver |
10.3B | 35 | 0.16 | 27 | 97 | - |
| BIM PA Biomerieux |
Biotechnology
Diagnostic Tests, Microbiology Systems, PCR |
9.90B | 47 | -0.77 | 85 | 3 | 2.1% |
| CYTK NASDAQ Cytokinetics |
Biotechnology
Muscle Activators, Muscle Inhibitors, Cardiac |
9.70B | 35 | -0.33 | 22 | 82 | - |
| KRYS NASDAQ Krystal Biotech |
Biotechnology
Gene Therapies, Topical Gels, Ophthalmic Drops |
8.87B | 65 | 0.65 | 68 | 94 | - |
| HALO NASDAQ Halozyme Therapeutics |
Biotechnology
Enzymes, Drug Delivery, Injectable Devices |
8.48B | 69 | -0.30 | 73 | 52 | - |
| ABVX NASDAQ Abivax American Depositary |
Biotechnology
Immunotherapies, Anti-Inflammatory Drugs |
8.09B | 41 | 0.32 | 49 | 99 | - |
| ABVX PA Abivax |
Biotechnology
Anti-Inflammatory Drugs, Biotechnology, Clinical |
8.07B | 42 | -0.10 | 51 | 99 | - |
| QIA XETRA QIAGEN |
Biotechnology
Sample Technologies, Diagnostic Assays, PCR |
7.59B | 37 | -0.60 | 85 | 11 | 5.3% |
| IBRX NASDAQ Immunitybio |
Biotechnology
Immunotherapies, Cytokine Fusion Proteins, Cancer |
7.25B | 39 | -0.26 | 23 | 97 | - |
| ALKS NASDAQ Alkermes |
Biotechnology
Antipsychotics, Injectable Suspensions, Addiction |
7.23B | 61 | 1.39 | 27 | 92 | - |
| PRAX NASDAQ Praxis Precision Medicines |
Biotechnology
Small Molecules, Antisense Oligonucleotides, CNS |
7.08B | 40 | -0.10 | 32 | 99 | - |
| NUVL NASDAQ Nuvalent |
Biotechnology
Kinase Inhibitors, Oncology Therapies, Precision |
7.02B | 37 | 0.21 | 44 | 85 | - |
| PCVX NASDAQ Vaxcyte |
Biotechnology
Pneumococcal Vaccines, Conjugate Vaccines |
6.84B | 18 | -1.58 | 26 | 43 | - |
| APGE NASDAQ Apogee Therapeutics, Common |
Biotechnology
Monoclonal Antibodies, Biologics, Immunology |
6.55B | 40 | 0.49 | 52 | 91 | - |
| IMVT NASDAQ Immunovant |
Biotechnology
Monoclonal Antibodies, Immunology Therapeutics |
6.39B | 39 | -0.04 | 49 | 91 | - |
| PTGX NASDAQ Protagonist Therapeutics |
Biotechnology
Oral Peptides, Hormone Mimetics, Injectable |
6.39B | 41 | -0.10 | 58 | 88 | - |
| SYRE NASDAQ Spyre Therapeutics |
Biotechnology
Monoclonal Antibodies, Immunotherapies |
6.38B | 40 | 0.12 | 47 | 99 | - |
| TGTX NASDAQ TG Therapeutics |
Biotechnology
Monoclonal Antibodies, Multiple Sclerosis, BTK |
6.21B | 37 | 0.95 | 26 | 90 | - |
| CNTA NASDAQ Centessa Pharmaceuticals |
Biotechnology
Orexin Agonists, Neuroscience Therapeutics |
6.17B | 37 | 0.37 | 43 | 96 | - |
| KYMR NASDAQ Kymera Therapeutics |
Biotechnology
Protein Degraders, Small Molecules, Immunology |
6.10B | 42 | -0.17 | 52 | 77 | - |
| LEGN NASDAQ Legend Biotech |
Biotechnology
Cell Therapies, CAR-T, Oncology, Immunotherapy |
6.06B | 29 | 1.19 | 46 | 88 | - |
| RYTM NASDAQ Rhythm Pharmaceuticals |
Biotechnology
Peptide Therapeutics, Obesity Pharmaceuticals |
5.93B | 26 | -1.71 | 34 | 21 | - |
| PTCT NASDAQ PTC Therapeutics |
Biotechnology
Rare Disease Medicines, Gene Therapies, Muscular |
5.89B | 32 | 0.36 | 36 | 69 | - |
| BLTE NASDAQ Belite Bio |
Biotechnology
Retinal Therapeutics, Liver Drugs, Metabolic |
5.75B | 34 | -0.39 | 46 | 86 | - |
| MIRM NASDAQ Mirum Pharmaceuticals |
Biotechnology
Bile Acid Inhibitors, Rare Disease Therapies |
5.70B | 34 | -0.88 | 34 | 85 | - |
| SRRK NASDAQ Scholar Rock Holding |
Biotechnology
Monoclonal Antibodies, Myostatin Inhibitors, TGFβ |
5.31B | 27 | -1.84 | 52 | 62 | - |
| COGT NASDAQ Cogent Biosciences |
Biotechnology
Kinase Inhibitors, Precision Medicines, Oncology |
5.30B | 42 | 0.06 | 46 | 96 | - |
| XENE NASDAQ Xenon Pharmaceuticals |
Biotechnology
Epilepsy Therapeutics, Anticonvulsants |
5.17B | 40 | -0.95 | 76 | 70 | - |
| CRSP NASDAQ Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapies, Immunotherapy |
5.10B | 15 | -1.16 | 34 | 22 | - |
| LGND NASDAQ Ligand Pharmaceuticals |
Biotechnology
Drug Delivery, Licensed Assets |
4.75B | 53 | -0.11 | 83 | 90 | - |
| CGON NASDAQ CG Oncology, Common stock |
Biotechnology
Oncolytic Immunotherapy, Bladder Cancer |
4.74B | 32 | -0.84 | 33 | 85 | - |
| INDV NASDAQ Indivior Ordinary Shares |
Biotechnology
Opioid Treatments, Addiction Medicine, Injectable |
4.45B | 68 | 1.60 | 62 | 92 | - |
| DNTH NASDAQ Dianthus Therapeutics |
Biotechnology
Monoclonal Antibodies, Fusion Proteins |
4.40B | 51 | 0.60 | 72 | 97 | - |
| TWST NASDAQ Twist Bioscience |
Biotechnology
Synthetic DNA, Oligo Pools, NGS Tools, Antibody |
4.31B | 38 | -0.11 | 28 | 97 | - |
| CELC NASDAQ Celcuity |
Biotechnology
Cancer Therapies, Kinase Inhibitors, Clinical |
4.31B | 41 | 0.06 | 45 | 98 | - |
| TVTX NASDAQ Travere Therapeutics |
Biotechnology
Kidney Medications, Metabolic Therapies, Orphan |
4.26B | 55 | 0.32 | 33 | 96 | - |
| ERAS NASDAQ Erasca |
Biotechnology
Oncology Drugs, Cancer Therapies, Kinase |
4.19B | 37 | 0.04 | 52 | 99 | - |
| DIA MI DiaSorin S.p.A. |
Biotechnology
Immunodiagnostics, Molecular Diagnostics, Testing |
4.09B | 40 | -0.19 | 83 | 22 | 1.8% |
| VCYT NASDAQ Veracyte |
Biotechnology
Genomic Tests, Cancer Diagnostics, Molecular |
3.93B | 77 | 0.90 | 96 | 90 | - |
| CPRX NASDAQ Catalyst Pharmaceuticals |
Biotechnology
Muscle Disease Drugs, Epilepsy Treatments, Rare |
3.83B | 60 | 1.02 | 78 | 85 | - |
| EWTX NASDAQ Edgewise Therapeutics |
Biotechnology
Small Molecules, Muscle Therapies, Cardiac Drugs |
3.83B | 40 | -0.01 | 46 | 93 | - |
| KNSA NASDAQ Kiniksa Pharmaceuticals |
Biotechnology
Biopharmaceuticals, Monoclonal Antibodies |
3.73B | 66 | -0.09 | 84 | 81 | - |
| ACAD NASDAQ ACADIA Pharmaceuticals |
Biotechnology
Psychosis Medication, Neurological Drugs, Rare |
3.69B | 29 | -1.16 | 71 | 16 | - |
| NAMS NASDAQ NewAmsterdam Pharma |
Biotechnology
Cardiovascular Drugs, Cholesterol Inhibitors |
3.68B | 27 | -1.20 | 30 | 38 | - |
| ORKA NASDAQ Oruka Therapeutics |
Biotechnology
Monoclonal Antibodies, Psoriasis Treatments |
3.63B | 40 | 0.64 | 45 | 99 | - |
| CRNX NASDAQ Crinetics Pharmaceuticals |
Biotechnology
Endocrine Therapeutics, Hormone Agonists, Hormone |
3.47B | 21 | -1.15 | 31 | 17 | - |
| VKTX NASDAQ Viking Therapeutics |
Biotechnology
Obesity Drugs, Liver Therapies, Metabolic |
3.33B | 11 | -1.72 | 37 | 14 | - |
| DNLI NASDAQ Denali Therapeutics |
Biotechnology
Neurodegenerative Drugs, Lysosomal Therapies |
3.07B | 31 | -1.02 | 42 | 70 | - |
| BEAM NASDAQ Beam Therapeutics |
Biotechnology
Gene Editing, Stem Cell Therapy, Lipid |
3.05B | 34 | -1.61 | 42 | 82 | - |
| RLAY NASDAQ Relay Therapeutics |
Biotechnology
Oncology Drugs, Small Molecules, Genetic |
2.95B | 42 | -0.32 | 49 | 98 | - |
| TNGX NASDAQ Tango Therapeutics |
Biotechnology
Oncology Drugs, PRMT5 Inhibitors, Precision |
2.92B | 39 | 0.63 | 42 | 99 | - |
| RCUS NYSE Arcus Biosciences |
Biotechnology
Cancer Therapies, Antibodies, Small Molecule |
2.92B | 36 | -1.19 | 20 | 86 | - |
| DYN NASDAQ Dyne Therapeutics |
Biotechnology
Oligonucleotides, Muscle Therapeutics, Genetic |
2.82B | 27 | -1.51 | 54 | 42 | - |
| ARQT NASDAQ Arcutis Biotherapeutics |
Biotechnology
Topical Creams, Therapeutic Foams, Fusion |
2.66B | 48 | -0.96 | 33 | 63 | - |
| GRAL NASDAQ GRAIL |
Biotechnology
Cancer Screening, Diagnostic Aids, Precision |
2.62B | 37 | -1.01 | 40 | 76 | - |
| GPCR NASDAQ Structure Therapeutics |
Biotechnology
Obesity Drugs, Diabetes Treatments, Pulmonary |
2.62B | 29 | -0.46 | 43 | 72 | - |
| IRON NASDAQ Disc Medicine |
Biotechnology
Hematology Drugs, Anemia Treatments, Iron |
2.56B | 28 | -1.47 | 50 | 39 | - |
| IDYA NASDAQ Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Precision Medicine |
2.49B | 16 | -1.65 | 18 | 20 | - |
| ALMS NASDAQ Alumis |
Biotechnology
TYK2 Inhibitors, Monoclonal Antibodies |
2.43B | 40 | -0.01 | 24 | 99 | - |
| CLDX NASDAQ Celldex Therapeutics |
Biotechnology
Monoclonal Antibodies, Bispecific Antibodies |
2.34B | 28 | -0.80 | 31 | 54 | - |
| VERA NASDAQ Vera Therapeutics |
Biotechnology
Fusion Proteins, Monoclonal Antibodies |
2.32B | 24 | -1.88 | 52 | 27 | - |
| PHVS NASDAQ Pharvaris BV |
Biotechnology
Angioedema Therapies, Receptor Antagonists, Small |
2.17B | 36 | 0.60 | 52 | 86 | - |
| RARE NASDAQ Ultragenyx |
Biotechnology
Antibodies, Enzyme Therapies, Gene Therapies |
2.16B | 13 | -0.97 | 34 | 9 | - |
| BCRX NASDAQ BioCryst Pharmaceuticals |
Biotechnology
Hereditary Angioedema Treatments, Antivirals |
2.11B | 27 | -0.69 | 29 | 20 | - |
| IMNM NASDAQ Immunome |
Biotechnology
Antibody-Drug Conjugates, Oncology Therapeutics |
2.10B | 38 | -0.49 | 37 | 83 | - |
| MLYS NASDAQ Mineralys Therapeutics |
Biotechnology
Hypertension Drugs, Kidney Treatments |
2.05B | 27 | -1.22 | 36 | 15 | - |
| AUPH NASDAQ Aurinia Pharmaceuticals |
Biotechnology
Immunosuppressants, Autoimmune Therapies, Oral |
2.04B | 57 | 0.45 | 33 | 81 | - |
| KOD NASDAQ Kodiak Sciences |
Biotechnology
Retinal Therapeutics, Antibody Biopolymers |
1.94B | 40 | 0.27 | 50 | 99 | - |
| NTLA NASDAQ Intellia Therapeutics |
Biotechnology
Gene Editing, CRISPR Technology, In Vivo |
1.89B | 29 | -0.47 | 20 | 62 | - |
| STOK NASDAQ Stoke Therapeutics |
Biotechnology
Antisense Oligonucleotides, Genetic Medicines |
1.87B | 34 | -0.75 | 33 | 76 | - |
| ZLAB NASDAQ Zai Lab |
Biotechnology
Oncology Drugs, Immunology Treatments |
1.86B | 8 | -1.58 | 15 | 6 | - |
| VCEL NASDAQ Vericel Ord |
Biotechnology
Cartilage Implants, Skin Replacements, Burn |
1.85B | 49 | -0.33 | 59 | 43 | - |
| IOVA NASDAQ Iovance Biotherapeutics |
Biotechnology
Cell Therapies, Immunotherapy, Interleukin-2 |
1.84B | 35 | -0.80 | 29 | 80 | - |
| ADMA NASDAQ ADMA Biologics |
Biotechnology
Immune Globulin, Polyclonal Antibodies, Human |
1.80B | 37 | -1.07 | 86 | 1 | - |
| GLPG AS Galapagos |
Biotechnology
Immunology Drugs, Oncology Drugs, Cell Therapies |
1.79B | 36 | -0.59 | 56 | 14 | - |
| NANO PA Nanobiotix S.A |
Biotechnology
Nanoparticles, Cancer Therapeutics, Radiotherapy |
1.78B | 37 | 0.30 | 45 | 99 | - |
| ZYME NASDAQ Zymeworks Common Stock |
Biotechnology
Bispecific Antibodies, Antibody-Drug Conjugates |
1.77B | 25 | -0.93 | 24 | 72 | - |
| RXRX NASDAQ Recursion Pharmaceuticals |
Biotechnology
Oncology Drugs, Genetic Medicines, Drug Discovery |
1.76B | 11 | -1.15 | 21 | 5 | - |
| VRDN NASDAQ Viridian Therapeutics |
Biotechnology
Monoclonal Antibodies, IGF-1R Inhibitors, TSHR |
1.75B | 21 | -0.97 | 52 | 4 | - |
| ABCL NASDAQ Abcellera Biologics |
Biotechnology
Antibodies, Discovery Platform, Monoclonal |
1.72B | 46 | 0.00 | 49 | 88 | - |
| AGIO NASDAQ Agios Pharm |
Biotechnology
Metabolic Medicines, Enzyme Activators, Rare |
1.68B | 23 | 0.08 | 26 | 20 | - |
| PHM MC Pharma Mar S.A. |
Biotechnology
Oncology Drugs, Cancer Treatments, Marine |
1.68B | 48 | -1.51 | 68 | 23 | 1.0% |
| NUVB NYSE Nuvation Bio |
Biotechnology
Cancer Therapeutics, ROS1 Inhibitors, IDH1 |
1.68B | 51 | -1.00 | 31 | 66 | - |
| QURE NASDAQ Uniqure |
Biotechnology
Gene Therapies, Hemophilia Treatments, Rare |
1.67B | 36 | 0.64 | 36 | 91 | - |
| SRPT NASDAQ Sarepta Therapeutics |
Biotechnology
Gene Therapy, RNA Therapeutics, Rare Disease Drugs |
1.66B | 36 | -1.11 | 53 | 5 | - |
| BHVN NYSE Biohaven |
Biotechnology
Neuroscience Drugs, Immunology Treatments |
1.63B | 20 | -1.20 | 42 | 19 | - |
| SLS NASDAQ Sellas Life Sciences |
Biotechnology
Immunotherapies, Cancer Vaccines, CDK9 |
1.62B | 38 | 0.41 | 34 | 99 | - |
| SION NASDAQ Sionna Therapeutics, Common |
Biotechnology
Cystic Fibrosis Drugs, CFTR Correctors, CFTR |
1.60B | 33 | -1.57 | 46 | 72 | - |
| TSHA NASDAQ Taysha Gene Therapies |
Biotechnology
Gene Therapies, Viral Vectors, Neurological |
1.58B | 40 | -0.90 | 54 | 88 | - |
| TYRA NASDAQ Tyra Biosciences |
Biotechnology
Precision Medicines, Oncology Drugs, Genetic |
1.57B | 36 | -0.69 | 41 | 88 | - |
| NVAX NASDAQ Novavax |
Biotechnology
Vaccines, Adjuvants, Infectious Diseases |
1.56B | 19 | -1.46 | 25 | 38 | - |
| PVLA NASDAQ Palvella Therapeutics |
Biotechnology
Topical Rapamycin, Topical Pitavastatin, Skin |
1.56B | 36 | -1.08 | 38 | 94 | - |
| CAPR NASDAQ Capricor Therapeutics |
Biotechnology
Cell Therapies, Exosome Platforms, Vaccines, RNA |
1.55B | 40 | -0.31 | 52 | 94 | - |
| NRIX NASDAQ Nurix Therapeutics |
Biotechnology
BTK Degraders, CBL-B Inhibitors, IRAK4 Degraders |
1.51B | 28 | -1.00 | 46 | 60 | - |
| SNDX NASDAQ Syndax Pharmaceuticals |
Biotechnology
Menin Inhibitors, Monoclonal Antibodies, HDAC |
1.51B | 25 | -0.86 | 19 | 27 | - |
| ANAB NASDAQ AnaptysBio |
Biotechnology
Monoclonal Antibodies, Immunology Therapeutics |
1.51B | 56 | 0.09 | 32 | 98 | - |
| PURR NASDAQ Hyperliquid Strategies |
Biotechnology
Digital Assets, Treasury Management, Staking |
1.50B | 40 | -0.25 | 60 | 96 | - |
| GHRS NASDAQ GH Research |
Biotechnology
Psychedelics, Inhalable Therapies |
1.47B | 29 | -0.68 | 28 | 89 | - |
| VIR NASDAQ Vir Biotechnology |
Biotechnology
Monoclonal Antibodies, Antivirals |
1.46B | 29 | -0.63 | 27 | 76 | - |
| ATAI NASDAQ ATAI Life Sciences BV |
Biotechnology
Psychedelics, Mental Health Drugs |
1.45B | 32 | -1.37 | 16 | 41 | - |
| IMCR NASDAQ Immunocore Holdings |
Biotechnology
Cancer Immunotherapies, T-Cell Engagers |
1.44B | 30 | -0.81 | 65 | 9 | - |
| KALV NASDAQ Kalvista Pharmaceuticals |
Biotechnology
Oral Therapies, Enzyme Inhibitors, Rare Disease |
1.43B | 48 | 1.46 | 41 | 94 | - |
| MBX NASDAQ MBX Biosciences, Common |
Biotechnology
Peptide Therapies, Endocrine Drugs, Metabolic |
1.43B | 40 | -0.04 | 45 | 96 | - |
| AVBP NASDAQ ArriVent BioPharma, Common |
Biotechnology
Kinase Inhibitors, Antibody Drug Conjugates |
1.41B | 35 | -0.68 | 46 | 83 | - |
| GLUE NASDAQ Monte Rosa Therapeutics |
Biotechnology
Molecular Glue Degraders, Small Molecules |
1.38B | 47 | 0.25 | 64 | 97 | - |
| ARDX NASDAQ Ardelyx |
Biotechnology
Gastrointestinal Medicine, Kidney Disease |
1.37B | 28 | -1.60 | 28 | 37 | - |
| IMTX NASDAQ Immatics |
Biotechnology
Cell Therapies, TCR Bispecifics, Cancer |
1.34B | 30 | -1.26 | 20 | 60 | - |
| MLTX NASDAQ MoonLake Immunotherapeutics |
Biotechnology
Biotechnology, Immunotherapies, Nanobodies |
1.32B | 17 | -1.13 | 52 | 7 | - |
| BCAX NASDAQ Bicara Therapeutics Common |
Biotechnology
Bifunctional Antibodies, Cancer Therapies |
1.31B | 35 | -1.44 | 33 | 81 | - |
| URGN NASDAQ UroGen Pharma |
Biotechnology
Bladder Cancer Drugs, Hydrogel Technology |
1.31B | 48 | 0.33 | 33 | 97 | - |
| INBX NASDAQ Inhibrx Biosciences |
Biotechnology
Biologics, Cancer Therapeutics, Antibody Therapies |
1.31B | 38 | 0.24 | 29 | 99 | - |
| MPLT NASDAQ MapLight Therapeutics |
Biotechnology
Neurological Pharmaceuticals, Muscarinic |
1.29B | 42 | -0.87 | 46 | 91 | - |
| PGEN NASDAQ Precigen |
Biotechnology
Gene Therapies, Cell Therapies, Immunotherapies |
1.28B | 39 | -0.36 | 17 | 86 | - |
| CDNA NASDAQ CareDx |
Biotechnology
Transplant Diagnostics, Genetic Testing |
1.16B | 63 | 0.74 | 73 | 87 | - |
| MEDCL PA Medincell |
Biotechnology
Injectable Pharmaceuticals, Drug Delivery |
1.11B | 39 | -0.42 | 46 | 82 | - |
| ZBIO NASDAQ Zenas BioPharma, Common |
Biotechnology
Monoclonal Antibodies, Immunology Therapies |
1.10B | 28 | -0.86 | 41 | 12 | - |
| OPK NASDAQ Opko Health |
Biotechnology
Diagnostic Tests, Hormones, Vaccines, Therapeutic |
1.09B | 21 | -0.47 | 34 | 56 | - |
| MNKD NASDAQ MannKind |
Biotechnology
Inhaled Insulin, Delivery Devices, Pulmonary |
1.05B | 20 | -0.22 | 25 | 27 | - |
| DBVT NASDAQ DBV Technologies |
Biotechnology
Immunotherapy Patches, Allergy Treatments |
1.05B | 36 | -0.53 | 37 | 62 | - |
| SVRA NASDAQ Savara |
Biotechnology
Inhaled Biopharmaceuticals, Respiratory |
1.04B | 41 | -1.37 | 30 | 76 | - |
| BTX NYSE BlackRock Technology |
Biotechnology
Technology Equities, Private Equity, Term Trust |
1.02B | 28 | -0.64 | 23 | 86 | 10.7% |
| ABSI NASDAQ Absci |
Biotechnology
Antibody Therapeutics, Biopharmaceuticals, Drug |
998M | 37 | 0.24 | 41 | 98 | - |
| DBV PA DBV Technologies S.A. |
Biotechnology
Immunotherapy Patches, Allergy Treatments |
972M | 30 | -0.82 | 25 | 63 | - |
| CRVS NASDAQ Corvus Pharmaceuticals |
Biotechnology
ITK Inhibitors, A2A Antagonists, Monoclonal |
954M | 37 | -0.65 | 42 | 89 | - |
| OLMA NASDAQ Olema Pharmaceuticals |
Biotechnology
Breast Cancer Therapies, Estrogen Receptor |
901M | 32 | -0.95 | 38 | 39 | - |
| ANNX NASDAQ Annexon |
Biotechnology
Monoclonal Antibodies, Small Molecules |
867M | 42 | -1.07 | 41 | 81 | - |
| SPRY NASDAQ ARS Pharmaceuticals |
Biotechnology
Intranasal Epinephrine, Allergy Treatment, Nasal |
850M | 14 | -1.35 | 21 | 16 | - |
| LXRX NASDAQ Lexicon Pharmaceuticals |
Biotechnology
Heart Failure Drugs, Diabetes Medication, Pain |
848M | 37 | 0.17 | 25 | 94 | - |
| ABUS NASDAQ Arbutus Biopharma |
Biotechnology
RNAi Therapeutics, PD-L1 Inhibitors, Lipid |
847M | 42 | -0.96 | 22 | 19 | - |
| XNCR NASDAQ Xencor |
Biotechnology
Monoclonal Antibodies, Bispecific Antibodies |
847M | 22 | -1.62 | 66 | 45 | - |
| DRTS NASDAQ Alpha Tau Medical |
Biotechnology
Radiation Therapy, Medical Devices, Oncology |
845M | 32 | -0.58 | 41 | 97 | - |
| MGTX NASDAQ MeiraGTx Holdings |
Biotechnology
Gene Therapies, Viral Vectors, Genetic Medicines |
833M | 30 | -0.98 | 25 | 74 | - |
| CGEM NASDAQ Cullinan Oncology |
Biotechnology
Bispecific Antibodies, Small Molecules |
830M | 35 | -1.01 | 36 | 68 | - |
| JANX NASDAQ Janux Therapeutics |
Biotechnology
Immunotherapies, Cancer Therapeutics |
815M | 14 | -1.24 | 28 | 6 | - |
| ESPR NASDAQ Esperion Therapeutics |
Biotechnology
Cholesterol Medicines, Lipid Regulators |
808M | 44 | 0.28 | 24 | 87 | - |
| REPL NASDAQ Replimune |
Biotechnology
Oncolytic Immunotherapies, Cancer Therapeutics |
782M | 26 | -0.91 | 24 | 40 | - |
| ORIC NASDAQ Oric Pharmaceuticals |
Biotechnology
Cancer Therapies, Kinase Inhibitors, Epigenetic |
776M | 17 | -1.81 | 43 | 4 | - |
| KURA NASDAQ Kura Oncology |
Biotechnology
Menin Inhibitors, Farnesyltransferase Inhibitors |
776M | 24 | -1.27 | 27 | 28 | - |
| SANA NASDAQ Sana Biotechnology |
Biotechnology
Cell Therapies, Gene Engineering, Islet Cells |
746M | 15 | -0.85 | 33 | 11 | - |
| EVMN NYSE Evommune |
Biotechnology
Inflammation Therapies, Clinical Drugs |
717M | 21 | -1.28 | 42 | 27 | - |
| VOR NASDAQ Vor Biopharma |
Biotechnology
Fusion Proteins, Immunotherapies |
713M | 42 | -0.64 | 48 | 76 | - |
| AURA NASDAQ Aura Biosciences |
Biotechnology
Ocular Oncology, Bladder Cancer, Precision |
684M | 17 | -1.31 | 30 | 25 | - |
| DRUG NASDAQ Bright Minds Biosciences |
Biotechnology
Serotonin Agonists, Epilepsy Drugs |
677M | 37 | -1.23 | 54 | 71 | - |
| SLDB NASDAQ Solid Biosciences |
Biotechnology
Gene Therapies, Capsid Platforms, Genetic |
660M | 25 | -1.51 | 41 | 48 | - |
| DSGN NASDAQ Design Therapeutics |
Biotechnology
Small Molecules, Gene Therapies, Rare Disease |
659M | 45 | 0.12 | 53 | 92 | - |
| CTMX NASDAQ CytomX Therapeutics |
Biotechnology
Antibody-Drug Conjugates, T-Cell Engagers |
654M | 28 | -0.83 | 91 | 15 | - |
| ALLO NASDAQ Allogene Therapeutics |
Biotechnology
CAR T Therapies, Gene Editing, Immuno-oncology |
649M | 24 | -0.66 | 29 | 47 | - |
| CSTL NASDAQ Castle Biosciences |
Biotechnology
Molecular Diagnostics, Genetic Tests, Cancer |
637M | 41 | -0.92 | 91 | 11 | - |
| BBOT NASDAQ BridgeBio Oncology |
Biotechnology
Cancer Therapeutics, Small Molecules, KRAS |
630M | 10 | -1.41 | 10 | 3 | - |
| ZVRA NASDAQ Zevra Therapeutics |
Biotechnology
Rare Disease Drugs, ADHD Treatments, Metabolic |
627M | 77 | 0.03 | 63 | 89 | - |
| CADL NASDAQ Candel Therapeutics |
Biotechnology
Cancer Immunotherapies, Viral Vectors, Gene |
624M | 33 | -0.09 | 42 | 92 | - |
| CLYM NASDAQ Climb Bio |
Biotechnology
Monoclonal Antibodies, Immunotherapies, Clinical |
598M | 44 | 0.14 | 42 | 99 | - |
| IMMX NASDAQ Immix Biopharma |
Biotechnology
Cell Therapy, Immunotherapy, Biopharmaceuticals |
565M | 42 | -0.01 | 52 | 97 | - |
| MDXG NASDAQ MiMedx |
Biotechnology
Placental Allografts, Wound Care, Surgical |
557M | 35 | -1.04 | 80 | 3 | - |
| RIGL NASDAQ Rigel Pharmaceuticals |
Biotechnology
Hematology Drugs, Oncology Drugs, Kinase |
554M | 47 | -0.87 | 33 | 42 | - |
| PRME NASDAQ Prime Medicine, Common Stock |
Biotechnology
Gene Editing, Genetic Medicines, Prime Editors |
553M | 20 | -1.51 | 17 | 14 | - |
| TECX NASDAQ Tectonic Therapeutic |
Biotechnology
Therapeutic Proteins, GPCR Antibodies, Biologic |
547M | 28 | -1.61 | 56 | 69 | - |
| IRWD NASDAQ Ironwood Pharmaceuticals |
Biotechnology
Gastrointestinal Drugs, Peptide Analogs |
533M | 65 | 0.11 | 26 | 97 | - |
| XOMA NASDAQ XOMA Royalty |
Biotechnology
Biotech Royalties, Milestone Rights, Therapeutic |
528M | 56 | -0.14 | 29 | 88 | - |
| ALT NASDAQ Altimmune |
Biotechnology
Obesity Treatments, Liver Therapies, Peptide Drugs |
527M | 27 | -0.60 | 81 | 2 | - |
| ACHV NASDAQ Achieve Life Sciences |
Biotechnology
Smoking Cessation, Nicotine Dependence |
527M | 45 | 0.80 | 38 | 90 | - |
| VLA PA Valneva SE |
Biotechnology
Japanese Encephalitis, Cholera, Chikungunya, Lyme |
512M | 6 | -1.19 | 23 | 2 | - |
| ASMB NASDAQ Assembly Biosciences |
Biotechnology
Antivirals, Viral Therapeutics, Clinical |
460M | 26 | -1.26 | 43 | 14 | - |
| KYTX NASDAQ Kyverna Therapeutics |
Biotechnology
Cell Therapies, CAR T-Cells, Immunotherapies |
454M | 41 | -1.09 | 38 | 84 | - |
| FDMT NASDAQ 4D Molecular Therapeutics |
Biotechnology
Gene Therapies, Viral Vectors, Retinal |
452M | 35 | -1.49 | 29 | 74 | - |
| OVID NASDAQ Ovid Therapeutics |
Biotechnology
Epilepsy Medicines, Small Molecules, Neurological |
445M | 43 | -0.58 | 47 | 99 | - |
| PRTA NASDAQ Prothena |
Biotechnology
Monoclonal Antibodies, Immunotherapies, Vaccines |
443M | 33 | -1.44 | 28 | 23 | - |
| MYGN NASDAQ Myriad Genetics |
Biotechnology
Genetic Tests, Cancer Diagnostics, Prenatal |
432M | 12 | -0.98 | 31 | 7 | - |
| STRO NASDAQ Sutro Biopharma |
Biotechnology
Antibody Drug Conjugates, Vaccines, Protein |
427M | 48 | 0.09 | 24 | 98 | - |
| CCCC NASDAQ C4 Therapeutics |
Biotechnology
Protein Degraders, Oncology Therapeutics |
426M | 40 | 0.29 | 27 | 93 | - |
| NGNE NASDAQ Neurogene |
Biotechnology
Gene Therapies, Genetic Medicines, Neurological |
419M | 36 | -0.70 | 52 | 84 | - |
Technical
Structure
Fundamental
Topics in GIC Sub-Industry »Biotechnology« (200+)
- Monoclonal Antibodies
- Oncology Drugs
- Immunotherapies
- Gene Therapies
- Small Molecules
- Biopharmaceuticals
- Immunotherapy
- Genetic Medicines
- Kinase Inhibitors
- Cell Therapies
- Cancer Therapies
- Cancer Therapeutics
- Oncology Therapeutics
- Bispecific Antibodies
- Vaccines
- Immunology Drugs
- Antivirals
- Rare Disease Drugs
- Metabolic Treatments
- Gene Editing
- Fusion Proteins
- Viral Vectors
- Antibodies
- Biotechnology
- Gene Therapy
- Diagnostic Tests
- Biologics
- Precision Medicines
- Obesity Drugs
- Cardiovascular Drugs